Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Factors influencing the economics of biosimilars in the US.

× No keyword cloud information.

5 in total

1. Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings?

Authors: Stanton R Mehr; Richard A Brook
Journal: Pharmaceut Med Date: 2019-02

Review 2. The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy.

Authors: Eva Rahman Kabir; Shannon Sherwin Moreino; Mohammad Kawsar Sharif Siam
Journal: Biomolecules Date: 2019-08-24

3. Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review.

Authors: Yifei Liu; Min Yang; Vishvas Garg; Eric Q Wu; Jessie Wang; Martha Skup
Journal: Adv Ther Date: 2019-06-05 Impact factor: 3.845

Review 4. A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation.

Authors: Jorge J García; Luis E Raez; Daniel Rosas
Journal: Transl Lung Cancer Res Date: 2020-10

5. Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis.

Authors: Martin J Bergman; Alan J Kivitz; Dimitrios A Pappas; Joel M Kremer; Lixia Zhang; Anna Jeter; Johanna B Withers
Journal: Rheumatol Ther Date: 2020-08-14

5 in total